Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

about

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

Item

http://www.wikidata.org/entity/Q42377453

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

@en

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

@nl

type

Item

label

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

@en

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

@nl

prefLabel

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

@en

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

@nl

P1476

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

@en

P2093

A M Oliveira

http://www.w3.org/2001/XMLSchema#string

D M Silva

http://www.w3.org/2001/XMLSchema#string

F N Ramalho

http://www.w3.org/2001/XMLSchema#string

L N Ramalho

http://www.w3.org/2001/XMLSchema#string

M C Foss

http://www.w3.org/2001/XMLSchema#string

M J Augusto

http://www.w3.org/2001/XMLSchema#string

S C Sanches

http://www.w3.org/2001/XMLSchema#string

P2860

CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

A simple method for the isolation and purification of total lipides from animal tissues

Role of NADPH oxidases in the redox biology of liver fibrosis

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.

Angiotensin II receptor antagonists.

The renin angiotensin system and the metabolic syndrome

Insulin concentration modulates hepatic lipid accumulation in mice in part via transcriptional regulation of fatty acid transport proteins.

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.

P2888

s13098-017-0282-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13098-017-0282-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092219643

http://www.w3.org/2001/XMLSchema#string

P698

29046730

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

metabolic syndrome

P932

5640954

http://www.w3.org/2001/XMLSchema#string